Discover the Capgugel® Zephyr™ Dry-Powder Inhalation Capsule Portfolio Webinar
Air Date: Tuesday, November 12, 2019
Time: 11 AM ET | 5 PM CT | 8 AM PT
Dry-powder inhalation (DPI) is a major drug delivery technology for the treatment of respiratory diseases and increasingly for systemic drug delivery. Providing a uniform dose in a portable, easy-to-use system, capsule-based DPI is a simple and cost-effective way to deliver medication via the pulmonary route.
Within dry-powder inhalation application fields, Lonza offers the Capsugel® Zephyr™ Dry-Powder Inhalation portfolio: high-quality capsule solutions based on different polymers, tailored to enable consistent and optimal release performance. Polymer science and engineering have opened a new era of functional development, which offers the potential for selecting the right capsule for different APIs and different inhalation devices associated with a wider range of services.
Join us for a webinar on November 12th at 11 AM EST to learn more about the Capsugel® Zephyr™ Dry-Powder Inhalation capsule portfolio.
Claire Tardy, Ph.D., Research & Development Manager, Capsule Delivery Solutions, Lonza Pharma & Biotech
Claire has been an integral part of the Capsugel® family for almost 20 years. She started as a research engineer in 1999. In 2007, she moved into the role of Head of Research and in 2017 became Manager of Research and Development.
Claire has a Ph.D. in Sciences of Polymers from the Universities of Grenoble (France) and Leeds (UK). Claire has co-authored many articles and holds several patents within her area of expertise.
Frédérique Bordes-Picard, Business Manager, Development for Innovative Products, Capsule Delivery Solutions, Lonza Pharma & Biotech
Biochemical engineer by training (Bordeaux Polytechnic Institute), Frédérique also holds a Master of Business Administration from KEDGE Business School. Frédérique has been working in the pharmaceutical industry for more than 20 years: first at AstraZeneca UK, working on analytical development of therapeutic proteins and antibodies, then at CDMO Bertin Pharma (now Eurofins), working mainly on generic product development and licensing out. Frédérique joined Capsugel® in 2010 as Pharmaceutical Business Development Manager, providing technical and regulatory support for new capsule-based product developments.
Frédérique has developed specific expertise around capsule-based DPI product development and filing, supporting multiple companies in the EMEA and United States by working on innovative or generic DPI projects.